Tag: Informa

Informa Markets Fashion Elevates Talent and New Teams, Taking the Next Step Forward in Business … | Money

[email protected]_84 business strategies

The group has also added roles and elevated talent in other key areas including brand development, content and industry insights, and digital marketing to help bolster strategy as they further diversify their physical and digital product offer. A new Experience and Education division, dedicated to providing on-going educational opportunities, both on and offline, will cater to the varied needs of each brand vertical. Additionally, the group will continue with its expanded production of marketplace-exclusive content, highlighting and identifying timely industry insights and fashion resources also further driving differentiation and distinction in its event offering to the community.

“Adaptation, innovation, and evolution will be key as we move forward and the industry’s business needs are at the core of our strategic path ahead,” said Kelly Helfman, Commercial President for Informa Markets Fashion. “We’re fully focused on our customers’ commercial success and, by virtue, advancing our product offering to match their changing

… Read More
Read More

Informa Markets Fashion Elevates Talent and New Teams, Taking the Next Step Forward in Business Evolution

[email protected]_84 business strategies

Informa Markets Fashion announces development of new roles dedicated to supporting strategic business direction and expanding product offering to better serve the fashion wholesale industry.

Kelly Helfman

Kelly Helfman
Kelly Helfman
Kelly Helfman

Jason Peskin

Jason Peskin
Jason Peskin
Jason Peskin

Jordan Rudow

Jordan Rudow
Jordan Rudow
Jordan Rudow

NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) — Informa Markets Fashion announced today the next step in the group’s evolving strategic business direction with elevation of key talent into new roles and developing new teams. Informa’s Fashion portfolio brings together leading fashion brands and retailers in highly curated and expertly merchandised marketplaces, which ultimately serve to present consumers with the latest in quality apparel, footwear, accessories, and lifestyle products each season and at every price point. With the September 1st launch of its inaugural digital trade event in partnership with NuORDER, the group’s expanded catalog of product offerings, elevation of key talent, reorganization of teams,

… Read More
Read More

Informa Business Intelligence: Informa Pharma Intelligence Launches New Pulse Report: Clinical Trials & the COVID-19 Vaccine

[email protected]_84 business intelligence 

Findings Uncover More than 1 in 3 Americans Don’t Trust How Quickly COVID-19
Vaccine Clinical Trials Are Moving

LONDON, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the
global business intelligence provider for the biopharma industry, today
released its “Pulse Report: Clinical Trials & the COVID-19 Vaccine” study
which uncovered American sentiment and confidence around COVID-19 vaccine
clinical trials. According to the data, more than 1 in 3 (35%) Americans don’t
trust how quickly the COVID-19 vaccine clinical trials are moving, and more
than 1 in 5 (23%) don’t think pharmaceutical companies have consumers’ best
interests at mind during COVID-19 vaccine clinical trials.

The study conducted with third-party research firm YouGov, found that while
Americans are wary of the current vaccine development process, they are paying
attention to it with 22% saying they regularly look for updates on COVID-19
vaccine clinical trials. As such, developers must prioritize further education
… Read More
Read More

Informa Pharma Intelligence Launches New Pulse Report: Clinical Trials & the COVID-19 Vaccine – Press Release

[email protected]_84 business intelligence

LONDON, Oct. 01, 2020 (GLOBE NEWSWIRE) — Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today released its “Pulse Report: Clinical Trials & the COVID-19 Vaccine” study which uncovered American sentiment and confidence around COVID-19 vaccine clinical trials. According to the data, more than 1 in 3 (35%) Americans don’t trust how quickly the COVID-19 vaccine clinical trials are moving, and more than 1 in 5 (23%) don’t think pharmaceutical companies have consumers’ best interests at mind during COVID-19 vaccine clinical trials.

The study conducted with third-party research firm YouGov, found that while Americans are wary of the current vaccine development process, they are paying attention to it with 22% saying they regularly look for updates on COVID-19 vaccine clinical trials. As such, developers must prioritize further education and transparency around the process. Right now, 1 in 5 Americans agree that both pharmaceutical companies

… Read More
Read More